Funded startups/Proxima Bio, Inc.
PB

Proxima Bio, Inc.

SEC filing
Other Health Care · New York, NY
Form D on EDGAR
Amount raised$91.5Msold at filing
Total offering$91.5M
Investors in the raise11count reported to the SEC
FiledJun 10, 2026first sale Jan 12, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Jason PontinDirector
Zachary CarpenterExecutive Officer, Director
Alex GasnerDirector
John McFarlandExecutive Officer

Executive officers, directors and promoters as listed on the Form D.

Filing history

FormFiledAmount soldOffering
D/AJun 10, 2026$91.5M$91.5MEDGAR
DJan 21, 2026$86.3M$88.5MEDGAR